1. Home
  2. COLB vs CYTK Comparison

COLB vs CYTK Comparison

Compare COLB & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

COLB

Columbia Banking System Inc.

N/A

Current Price

$26.68

Market Cap

8.1B

Sector

Finance

ML Signal

N/A

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$63.20

Market Cap

7.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
COLB
CYTK
Founded
1993
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
7.6B
IPO Year
1996
2004

Fundamental Metrics

Financial Performance
Metric
COLB
CYTK
Price
$26.68
$63.20
Analyst Decision
Hold
Strong Buy
Analyst Count
14
18
Target Price
$31.32
$87.56
AVG Volume (30 Days)
2.7M
1.7M
Earning Date
04-22-2026
05-25-2026
Dividend Yield
5.49%
N/A
EPS Growth
N/A
N/A
EPS
2.30
N/A
Revenue
$177,000,000.00
$13,368,000.00
Revenue This Year
$31.85
$9.79
Revenue Next Year
$2.96
$302.66
P/E Ratio
$11.74
N/A
Revenue Growth
18.94
N/A
52 Week Low
$19.61
$29.31
52 Week High
$32.70
$70.98

Technical Indicators

Market Signals
Indicator
COLB
CYTK
Relative Strength Index (RSI) 29.25 50.00
Support Level $25.22 $59.25
Resistance Level $27.24 $65.93
Average True Range (ATR) 0.98 2.53
MACD -0.43 -0.18
Stochastic Oscillator 7.26 39.36

Price Performance

Historical Comparison
COLB
CYTK

About COLB Columbia Banking System Inc.

Columbia Banking System Inc is a registered bank holding company whose wholly-owned banking subsidiary is Columbia State Bank. The company provides a full range of banking services to small and medium sized businesses, professionals, and individuals throughout Washington, Oregon, Idaho, and California. The company's subsidiary Columbia Trust Company is an Oregon trust company that provides agency, fiduciary, and other related trust services with offices in Washington, Oregon, and Idaho. The firm offers various products and services under Personal Banking, Business Banking, and Wealth Management divisions.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: